09:00 am – 10:00 am – Cannabinoids in Food and Beverage: Market Trends, Innovation, and what the future holds
Food and beverage products from the Cannabis sativa plant have taken off, leading to the constant creation of innovative, new products to fill the cannabinoid-based food and beverage space. Looming in the background of constant growth is the FDA, which has yet to issue a final ruling that would set up an efficient regulatory framework for the industry. Learn about the most cutting-edge cannabinoid food and beverage products and explore what makes them true trend drivers. We will also explore the FDA and what a final ruling could mean for the food and beverage space within the cannabis umbrella.
10:15 am – 11:00 am – Keynote: COVID-19, Inflammation, and the Endocannabinoid System – How Are They Linked?
The leading cause of death from SARS-CoV2 is not from the virus itself, but from the immune system’s hyper inflammatory response to the virus. Cytokine Release Syndrome, otherwise known as “cytokine storm” leads to multi-organ failure that often begins in the lungs as “COVID pneumonia.” Treatment options for COVID-19 infections are currently limited. The endocannabinoid system’s activation leads to moderation of systemic inflammation and exploring how cannabinoids may play a role should be explored.
11:15 am – 12:00 pm – Study of the Competitive Environment in the CBD Space: Learn to Standout
The analysis of the condition of the CBD market and the definition of strategic targets on perspective changes are greatly pressing questions. Find out how to create a niche and boost your CBD sales by gaining big buyers and enlarging your footprint on product shelves. Learn the tips and tricks of gaining momentum in this ever-changing but highly competitive market.
12:15 pm – 1:00 pm – FDA Compliance And Regulations in California
It seems today that there are hundreds of reasons for the authorities to be heavy-handed on the regulations they impose. It can be a long-standing struggle for companies trying to keep up with the rapidly changing regulations. Companies that have to interact with authorities could face hefty fines at best and, at worst, a complete shutdown. California lawmakers are navigating this in their style as a legal medical marijuana state with a widespread hemp industry. Understanding California’s rules on advertising, sales, packaging, and more is crucial to creating a compliant and successful brand. Understand why it pays to follow the rules with this panel by pulling back the curtain and understanding requirements, processes, and protocols to maintain good standing with enforcement.
1:15 pm – 2:00 pm – How Much is Right for You: The Science of CBD Dosing
One of the challenges in the emerging CBD market is the lack of robust clinical research that can be used to guide dosing guidelines. This is especially problematic in people with comorbidities or on other medications who would like to explore taking these products medicinally too. Even so, crowdsourcing the anecdotal data has allowed companies to review by developing a functional measure of how much CBD is needed for different conditions. This system, albeit lacking in strong foundations in clinical trials, in some ways is good enough. But, when it comes to a product we want to promote as medication, we have a responsibility to produce real data from which to work off of.
02:15 pm – 03:00 pm – Creating CBD Formulations and Blends
While scores of people may benefit from CBD isolates, many more have reported respite from their ailments after using full-spectrum products containing more natural molecules native to hemps, like other cannabinoids and terpenes. Still, many product manufacturers are looking to design formulations that incorporate some of these molecules without necessarily being considered “full-spectrum”. To continue, these products may contain other minor cannabinoids and terpenes, but the inclusion of these ingredients is purposeful. Such as, creating products designed as sleep aids or treating pain or anxiety. Additionally, blending these formulations with other dietary supplements namely ginseng or melatonin can present an exciting new product line. In which, combines traditional supplements with the surging interest in hemp-derived molecules. Thereby, presenting the best of both worlds. This panel will help professionals understand what products are currently in demand and illustrate how the rapidly evolving CBD industry is changing.
03:15 pm – 04:00 pm – Psychedelics & Cannabinoid Therapeutics: What Does the Future Hold?
Alongside the CBD boom, the functional mushroom market has experienced a profound amount of growth with certain estimates putting market growth upwards of $35 billion. Similarly situated to cannabis treatments as both controversial and poorly understood, there remains tremendous potential on the horizon for mycelia like, cordycepin and psilocybin. As consumers look to herbal treatments for an assortment of ailments, quality of life improves the future of hemp products/mushrooms, and regulations take shape…the question remains whether or not there is a future for CBD and mushrooms.
4:15 pm – 5:00 pm – How to Approach CBD Marketing For Entrepreneurs and Start-Ups: Q&A
So you started a cannabidiol business and are looking to scale up but not sure how? The key to a successful company is good marketing–and CBD is no exception. But, even for seasoned pros, the transition to CBD may be a bit bumpy. The blossoming industry is going through some growing pains as regulators work to come up with guidelines. To avoid chaos, consider developing marketing messages that are based on the science of the product and reflect the needs of the consumer/patient audience. A strategic integrated approach targeted to key stakeholders with messages that carefully balance product/service benefits is a good start to kick off long-lasting relationships with patients and consumers.
